Inhibiting MNK kinases promotes macrophage immunosuppressive phenotype to limit anti-tumor immunity.

被引:0
|
作者
Pham, Thao N. D. [1 ]
Spaulding, Christina [1 ]
Shields, Mario A. [1 ]
Khalafalla, Mahmoud G. [1 ]
Principe, Daniel R. [2 ]
Bentrem, David J. [1 ]
Munshi, Hidayatullah G. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Univ Illinois, Coll Med, Med Scientist Training Program, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-049
引用
收藏
页码:34 / 34
页数:1
相关论文
共 50 条
  • [21] eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade
    Webster, Kevin R.
    Goel, Vikas K.
    Staunton, Jocelyn
    Hung, Ivy N. J.
    Parker, Gregory S.
    Stumpf, Craig R.
    Molter, Jolene
    Chiang, Gary G.
    Wegerski, Christopher J.
    Sperry, Samuel
    Chen, Joan
    Huang, Vera
    Thompson, Peggy A.
    Tran, Chinh
    Ernst, Justin T.
    Webber, Stephen E.
    Sprengeler, Paul A.
    Reich, Siegfried H.
    CANCER RESEARCH, 2017, 77
  • [22] Marvelon suppresses MC38 tumor growth and promotes anti-tumor immunity
    Kong, Fandi
    Chen, Yongyan
    Liu, Dantong
    Gao, Hongying
    Yi, Qiaoru
    Zhang, Mengjuan
    Li, Dan
    MOLECULAR IMMUNOLOGY, 2025, 182 : 20 - 29
  • [23] BRD7 negatively regulates tumor angiogenesis and a promotes anti-tumor immunity
    van Beijnum, Judy R.
    Wong, Tse
    van Berkel, Maaike
    Hautvast, Petra
    van den Boezem, Edith
    Griffioen, Arjan W.
    ANGIOGENESIS, 2014, 17 (03) : 747 - 747
  • [24] Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.
    Anthoney, Alan
    Samson, Adel
    West, Emma
    Turnbull, Samantha Jane
    Scott, Karen
    Tidswell, Emma
    Kingston, Jennifer
    Johnpulle, Michelle
    Noutch, Samantha
    Bendjama, Kaidre
    Homerin, Michel
    Stojkowitz, Nicolas
    Toogood, Giles
    Twelves, Chris
    Ralph, Christy
    Melcher, Alan
    Collinson, Fiona Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
    Ma, Shoubao
    Xiao, Sai
    Caligiuri, Michael
    Yu, Jianhua
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [26] Inhibiting the CCR2/MCP-1 chemokine pathway blocks MDSC recruitment and promotes anti-tumor immunity
    Mittel, Payal
    Wang, Liqing
    Akimova, Tatiana
    Leach, Craig A.
    Clemente, Jose C.
    Sender, Mathew
    Chen, Yao
    Turenen, Brandon
    Hancock, Wayne W.
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Reprogramming-based gene therapy promotes anti-tumor immunity in vivo
    Anania, Chiara
    NATURE GENETICS, 2024, 56 (10) : 1999 - 1999
  • [28] Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity
    Natoli, Marina
    Herzig, Petra
    Pishali Bejestani, Elham
    Buchi, Melanie
    Ritschard, Reto
    Lloyd, G. Kenneth
    Mohanlal, Ramon
    Tonra, James R.
    Huang, Lan
    Heinzelmann, Viola
    Trub, Marta
    Zippelius, Alfred
    Kashyap, Abhishek S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
    Xao X. Tang
    Hiroyuki Shimada
    Naohiko Ikegaki
    Genes & Immunity, 2022, 23 : 129 - 140
  • [30] Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
    He, Kun
    Jia, Shengguo
    Lou, Yue
    Liu, Ping
    Xu, Lisa X.
    CELL DEATH & DISEASE, 2019, 10 (3)